Published in
American Association for the Advancement of Science, Science Translational Medicine, 264(6), 2014
DOI: 10.1126/scitranslmed.3010083
Links
Tools
Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa
Journal article published in 2014 by
Daniel Wenzel,
Jonathan Bayerl,
Alexander Nystrom 
,
Leena Bruckner-Tuderman,
Arabella Meixner,
Josef M. Penninger
,
Leena Bruckner-Tuderman,
Arabella Meixner,
Josef M. Penninger
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
iPSCs derived from fibroblasts with mutant type VII collagen were genetically corrected and used as cell therapy in mice with recessive dystrophic epidermolysis bullosa.